Teachers and staff at McCourt Middle School, as well as the community at-large, took solidarity to a new level last Thursday, Oct. 31, during their Golden Glow Day ...

About Aptevo Therapeutics Inc. Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel immuno-oncology therapies for the treatment of cancer. Aptevo is seeking ...

Weinstein was specifically diagnosed with chronic myeloid leukemia, NBC News reported ... executive producer was hospitalized with COVID-19 and double pneumonia. He recovered at the Bellevue ...

Secondary hematological malignancies, including myelodysplastic syndrome and acute myeloid leukemia, have occurred in patients ... 2.5% of which were due to COVID-19. Patients treated with CARVYKTI ® ...

Colon cancer patient achieved stable disease and remained on study for more than six months, breast cancer patient remained on study for more than 11 monthsBiomarker analysis confirms immune activatio ...

Researchers have identified a key weakness in acute myeloid leukemia, offering a promising new strategy to delay the ...

Researchers from the Tumor Profiler consortium have combined single-cell multi-omics and functional profiling for 21 AML ...

Secondary acute myeloid leukemia (AML) is a blood cancer that arises from other blood disorders or previous cancer treatment. Those with secondary AML tend to have a less favorable outlook than ...

Acute myeloid leukemia is a type of blood cancer in which the bone marrow makes excess numbers of abnormal immature white blood cells known as myeloblasts. Myelodysplastic syndrome refers to a ...

while AXL inhibition in macrophages may enhance the myeloid-centered anti-leukemia immune response. Dr. Kiyean Nam, CEO of Qurient, conveyed his enthusiasm for the company’s strategic trajectory ...